These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12879631)

  • 1. [Statin therapy].
    Hitzenberger G
    Wien Med Wochenschr; 2003; 153(11-12):242-3. PubMed ID: 12879631
    [No Abstract]   [Full Text] [Related]  

  • 2. What you should know about: statins.
    Harv Health Lett; 2012 Oct; 37(12):7. PubMed ID: 23243693
    [No Abstract]   [Full Text] [Related]  

  • 3. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
    Masana L; Pedro-Botet J; Civeira F
    Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557
    [No Abstract]   [Full Text] [Related]  

  • 4. What you need to know about statins. Statins are the most commonly-prescribed drug and have revolutionized heart health.
    Heart Advis; 2009 Apr; 12(4):6-7. PubMed ID: 20387254
    [No Abstract]   [Full Text] [Related]  

  • 5. A Statin for All Diabetics? Not So Fast ..
    Bowden J; Sinatra D; Sinatra S
    Altern Ther Health Med; 2015; 21(5):12-5. PubMed ID: 26393986
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for lipids.
    Treat Guidel Med Lett; 2011 Mar; 9(103):13-20. PubMed ID: 21350395
    [No Abstract]   [Full Text] [Related]  

  • 7. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is statin use safe in individuals with psychotic disorders?
    Mascitelli L; Pezzetta F; Goldstein MR
    J Clin Psychiatry; 2008 Sep; 69(9):1499. PubMed ID: 19193350
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins: putting the benefit/risk into perspective.
    Shepherd J
    Int J Clin Pract Suppl; 2003 Oct; (137):27-33. PubMed ID: 14649699
    [No Abstract]   [Full Text] [Related]  

  • 11. What role for [black triangle down] colesevelam in cardiovascular prevention?
    Drug Ther Bull; 2009 May; 47(5):53-5. PubMed ID: 19423677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary.
    Mooradian AD
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):598; author reply 602. PubMed ID: 16094774
    [No Abstract]   [Full Text] [Related]  

  • 13. Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?
    Aronow WS
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):591-2. PubMed ID: 15972605
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of statin therapy in patients with preexisting liver disease.
    Onofrei MD; Butler KL; Fuke DC; Miller HB
    Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and diabetes risk.
    Med Lett Drugs Ther; 2014 Sep; 56(1450):79-80. PubMed ID: 25157682
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 17. How aggressively should cholesterol targets be pursued?
    Wierzbicki AS
    Br J Hosp Med (Lond); 2007 May; 68(5):232-3. PubMed ID: 17554938
    [No Abstract]   [Full Text] [Related]  

  • 18. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Aim low.
    Nash IS
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):599-600; author reply 602. PubMed ID: 15972609
    [No Abstract]   [Full Text] [Related]  

  • 19. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary.
    Levy DR; Pearson TA
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):597-8; author reply 602. PubMed ID: 16094772
    [No Abstract]   [Full Text] [Related]  

  • 20. Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Cholesterol and the aged: ...and the beat goes on.
    Wilson MM
    J Gerontol A Biol Sci Med Sci; 2005 May; 60(5):600-2; author reply 602. PubMed ID: 15972610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.